2019
Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents.
Giri S, Huntington S, Wang R, Zeidan A, Podoltsev N, Gore S, Ma X, Gross C, Davidoff A, Neparidze N. Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents. Journal Of Clinical Oncology 2019, 37: 8044-8044. DOI: 10.1200/jco.2019.37.15_suppl.8044.Peer-Reviewed Original ResearchOverall survivalMultiple myelomaPerformance statusMultivariable Cox survival analysisMedian overall survivalPoor performance statusLines of therapyKaplan-Meier methodCox regression analysisDays of diagnosisWorse overall survivalCox survival analysisLog-rank testReal-world treatmentCommon genetic mutationsHigh-risk mutationsSitu hybridization testingElectronic health recordsISS stageReal-world practiceMedian ageMeier methodOS independentPrimary outcomeSpecific regimens
2014
The Impact of Marital and Socioeconomic Status on Outcomes of Patients with Acute Promyelocytic Leukemia
Huntington S, Shah N, Epstein A, Loren A. The Impact of Marital and Socioeconomic Status on Outcomes of Patients with Acute Promyelocytic Leukemia. Blood 2014, 124: 1282. DOI: 10.1182/blood.v124.21.1282.1282.Peer-Reviewed Original ResearchAcute promyelocytic leukemiaCurable hematological malignancyOutcomes of patientsArea Health Resource FileLong-term survivalHematological malignanciesSocioeconomic statusMarital statusPatient factorsPromyelocytic leukemiaLong-term overall survivalImproved long-term survivalUninsurance ratesIncurable metastatic diseaseCox regression analysisIndividual patient factorsEnd Results ProgramImportant patient factorsMultivariable logistic regressionAcute medical careTiming of presentationLikelihood of deathSocioeconomic factorsSocial supportSocioeconomic status index